Orchard Therapeutics
A Scientist I in Global Technical Development at a biotechnology company is involved in research and development activities to advance scientific knowledge and support product innovation. The role collaborates across teams and contributes to scientific projects in the biotech industry.
Headquarters
London, England, United Kingdom
Company Size
51-200 employees
Founded
2015
Orchard Therapeutics is a biotechnology company focused on developing ex vivo autologous hematopoietic stem cell gene therapies for rare genetic diseases. They harvest a patient’s own cells, genetically modify them with lentiviral vectors to restore missing or defective enzymes, and reinfuse them to provide durable therapeutic benefit. The programs aim to deliver one-time, curative treatments that modify disease trajectories and improve long-term outcomes. Orchard emphasizes rigorous clinical development and scalable manufacturing to bring these therapies to patients worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Orchard Therapeutics.
Orchard Therapeutics didn’t post a salary, so this is our estimate from similar listings.
4% below the average for this role
Kyowa Kirin acquires Orchard Therapeutics for $477.6m
Jan 25, 2024